Bionovo Appoints Steven R. Goldstein, M.D., to their Medical Advisory Board

Rochester, New York 11/05/2009 08:15 PM GMT (TransWorldNews)

Bionovo, Inc. (NASDAQ: BNVI) has appointed Steven R. Goldstein, M.D., to the company's Medical Advisory Board. Dr. Goldstein is a world leader on uterine safety. He has an extensive experience in menopausal and perimenopausal uterine safety studies for several Selective Estrogen Receptor Modulators (SERMS). He graduated Magna Cum Laude from Colgate University with a Baccalaureate degree in Biology. He graduated from the New York University School of Medicine in 1975.

Penny Stock Professor, a leading financial publication, is pleased to alert investors of stocks on the move. Sign Up for our Free Penny Stock Picks.

Bionovo, Inc.

Bionovo is a pharmaceutical company focused on the discovery and development of safe and effective treatments for women's health and cancer, markets with significant unmet needs and billions in potential annual revenue. The company applies its expertise in the biology of menopause and cancer to design new drugs derived from botanical sources which have novel mechanisms of action. Based on the results of early and mid-stage clinical trials, Bionovo believes they have discovered new classes of drug candidates within their rich pipeline with the potential to be leaders in their markets.

Sign up for the free Penny Stock Professor newsletter. To subscribe, enter your e-mail address into the frame at the bottom of this press release or visit our website.

About Us

Penny Stock Professor is a leading stock web site that allows investors and interested parties to research stocks that are on the move. We also track small cap companies that are on the brink of a financial breakout. To feature a company on our web site please contact us at the email listed below.

Please click here to read the full disclaimer.